pI: 7.8051 |
Length (AA): 270 |
MW (Da): 29962 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
15 | 263 | 1j2p (A) | 7 | 233 | 21.00 | 0 | 1 | 1.09 | -0.38 |
42 | 224 | 1ryp (L) | 1 | 185 | 26.00 | 0 | 1 | 1.15 | -1.34 |
42 | 258 | 1iru (I) | 1 | 216 | 57.00 | 0 | 1 | 1.54 | -0.82 |
12 | 240 | 1j2p (A) | 4 | 233 | 22.00 | 0.00000022 | 1 | 1.13865 | -0.39 |
23 | 235 | 1yar (A) | 15 | 231 | 20.00 | 0.000054 | 1 | 1.07639 | -0.56 |
42 | 226 | 4r3o (H) | 1 | 186 | 26.00 | 0.0000000044 | 1 | 1.14469 | -1.08 |
42 | 262 | 4r3o (I) | 1 | 220 | 56.00 | 0 | 1 | 1.53502 | -0.65 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Oocyst, Ring, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, Sporozoite. | Otto TD Zanghi G |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_127705)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G40580 | 20S proteasome beta subunit PBB2 |
Arabidopsis thaliana | AT3G27430 | 20S proteasome beta subunit PBB1 |
Babesia bovis | BBOV_IV008660 | proteasome subunit beta 7, putative |
Brugia malayi | Bm1_30555 | Proteasome A-type and B-type family protein |
Candida albicans | CaO19.7605 | similar to S. cerevisiae PUP1 (YOR157C) proteasome subunit |
Caenorhabditis elegans | CELE_C47B2.4 | Protein PBS-2 |
Cryptosporidium hominis | Chro.30293 | proteasome component precursor |
Cryptosporidium parvum | cgd3_2530 | PUP1/proteasome subunit beta type 7, NTN hydrolase fold |
Dictyostelium discoideum | DDB_G0283679 | 20S proteasome subunit beta-7 |
Drosophila melanogaster | Dmel_CG3329 | Proteasome beta2 subunit |
Echinococcus granulosus | EgrG_000062300 | proteasome subunit beta type 7 |
Entamoeba histolytica | EHI_148040 | proteasome subunit beta type 7-B precursor, putative |
Echinococcus multilocularis | EmuJ_000062300 | proteasome subunit beta type 7 |
Giardia lamblia | GL50803_27059 | Proteasome subunit beta type 7 precursor |
Homo sapiens | ENSG00000136930 | proteasome (prosome, macropain) subunit, beta type, 7 |
Leishmania braziliensis | LbrM.34.3820 | proteasome beta 2 subunit, putative |
Leishmania donovani | LdBPK_353880.1 | proteasome beta 2 subunit, putative |
Leishmania infantum | LinJ.35.3880 | proteasome beta 2 subunit, putative |
Leishmania major | LmjF.35.3840 | proteasome beta 2 subunit, putative |
Leishmania mexicana | LmxM.34.3840 | proteasome beta 2 subunit, putative |
Loa Loa (eye worm) | LOAG_05524 | proteasome A-type and B-type family protein |
Mus musculus | ENSMUSG00000026750 | proteasome (prosome, macropain) subunit, beta type 7 |
Neospora caninum | NCLIV_053220 | PsmB (EC 3.4.25.1), related |
Oryza sativa | 4338009 | Os05g0187000 |
Plasmodium berghei | PBANKA_1343300 | proteasome subunit beta type-7, putative |
Plasmodium falciparum | PF3D7_1328100 | proteasome subunit beta type-7, putative |
Plasmodium knowlesi | PKNH_1200500 | proteasome subunit beta type-7, putative |
Plasmodium vivax | PVX_082355 | proteasome subunit beta type-7, putative |
Plasmodium yoelii | PY04957 | proteasome subunit, beta type, 7 |
Saccharomyces cerevisiae | YOR157C | proteasome core particle subunit beta 2 |
Schistosoma japonicum | Sjp_0002420 | ko:K02739 20S proteasome subunit beta 2, putative |
Schistosoma mansoni | Smp_073410 | proteasome catalytic subunit 2 (T01 family) |
Schmidtea mediterranea | mk4.000114.05 | Proteasome subunit beta type |
Schmidtea mediterranea | mk4.000114.14 | Proteasome subunit beta type |
Schmidtea mediterranea | mk4.000114.15 | Proteasome subunit beta type |
Trypanosoma brucei gambiense | Tbg972.9.6750 | proteasome beta 2 subunit, putative,20S proteasome subunit |
Trypanosoma brucei | Tb927.9.11330 | proteasome beta 2 subunit, putative |
Trypanosoma cruzi | TcCLB.508461.430 | proteasome beta 2 subunit, putative |
Toxoplasma gondii | TGME49_306930 | proteasome subunit beta type 7 precursor, putative |
Theileria parva | TP01_0908 | proteasome subunit beta type 7 precursor, putative |
Trichomonas vaginalis | TVAG_231360 | Family T1, proteasome beta subunit, threonine peptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.2590 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.2590 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.2590 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.2590 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C47B2.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C47B2.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C47B2.4 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C47B2.4 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C47B2.4 | Caenorhabditis elegans | sterile | wormbase |
YOR157C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_306930 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | proteasome (prosome, macropain) subunit, beta type, 7 | Compounds | References |
15 literature references were collected for this gene.